All Stories

  1. Prevalence and Intriguing Clinical Profiles of Autoimmune Inner Ear Diseases in Sudden Sensorineural Hearing Loss

    Article • Otology & Neurotology, December 2024, Wolters Kluwer Health

    Pongthorn Narongroeknawin

  2. Glucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus

    Article • International Journal of Rheumatology, November 2023, Wiley

    Pongthorn Narongroeknawin

  3. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000‐based remission states in patients with SLE on damage accrual

    Article • International Journal of Rheumatic Diseases, October 2023, Wiley

    Pongthorn Narongroeknawin

  4. Prevalence of low trabecular bone score and its association with disease severity and activity in patients with axial spondyloarthritis

    Article • Scientific Reports, September 2023, Springer Science + Business Media

    Pongthorn Narongroeknawin

  5. Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity

    Article • BMC Health Services Research, May 2023, Springer Science + Business Media

    Pongthorn Narongroeknawin

  6. Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARD), targeted synthetic DMARD (tsDMARD) and biosimilar DMARD (bsDMARD) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity

    Article • March 2023, Research Square

    Pongthorn Narongroeknawin

  7. Performance of systemic lupus erythematosus responder index for detecting clinician‐rated responders in patients with active systemic lupus erythematosus

    Article • International Journal of Rheumatic Diseases, February 2023, Wiley

    Pongthorn Narongroeknawin

  8. Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Pongthorn Narongroeknawin

  9. Risk Factors for Sarcopenia in Thai Patients with Rheumatoid Arthritis

    Article • Discovery Medicine, January 2023, Discovery Medicine

    Pongthorn Narongroeknawin

  10. Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort

    Article • Medicine, August 2022, Wolters Kluwer Health

    Pongthorn Narongroeknawin

  11. Prevalence and Risk factors for Sarcopenia in Thai Patients with Rheumatoid arthritis

    Article • July 2022, Research Square

    Pongthorn Narongroeknawin

  12. Trabecular Bone Score: a New Simple Tool for Evaluating Osteoporosis in Patients With Axial Spondyloarthritis

    Article • January 2022, Research Square

    Pongthorn Narongroeknawin

  13. Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region

    Article • The Lancet Regional Health - Western Pacific, October 2021, Elsevier

    Pongthorn Narongroeknawin

  14. Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis

    Article • Clinical Rheumatology, September 2020, Springer Science + Business Media

    Pongthorn Narongroeknawin

  15. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4‐related disease

    Article • International Journal of Rheumatic Diseases, August 2020, Wiley

    Pongthorn Narongroeknawin

  16. Effect of Curcumin on Serum Urate in Asymptomatic Hyperuricemia: A Randomized Placebo-Controlled Trial

    Article • Journal of Dietary Supplements, May 2020, Taylor & Francis

    Pongthorn Narongroeknawin

  17. Prevalence of and factors associated with depression and anxiety in patients with rheumatoid arthritis: A multicenter prospective cross‐sectional study

    Article • International Journal of Rheumatic Diseases, January 2020, Wiley

    Pongthorn Narongroeknawin

  18. Factors associated with and cutoff points for Patient Acceptable Symptom State (PASS) in rheumatoid arthritis

    Article • Clinical Rheumatology, December 2019, Springer Science + Business Media

    Pongthorn Narongroeknawin

  19. Group B streptococcus is the most common pathogen for septic arthritis with unique clinical characteristics: data from 12 years retrospective cohort study

    Article • BMC Rheumatology, September 2019, Springer Science + Business Media

    Pongthorn Narongroeknawin

  20. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study

    Article • Clinical Rheumatology, August 2019, Springer Science + Business Media

    Pongthorn Narongroeknawin

  21. Health-related quality of life in patients with rheumatoid arthritis

    Article • BMC Rheumatology, August 2019, Springer Science + Business Media

    Pongthorn Narongroeknawin

  22. Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus

    Article • Lupus, July 2019, SAGE Publications

    Pongthorn Narongroeknawin

  23. Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis

    Article • Clinical Rheumatology, March 2019, Springer Science + Business Media

    Pongthorn Narongroeknawin

  24. Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial

    Article • Patient Preference and Adherence, January 2019, Dove Medical Press

    Pongthorn Narongroeknawin

  25. Efficacy and Safety of Hepatitis B Vaccination in Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drugs and/or Biologics Therapy

    Article • JCR Journal of Clinical Rheumatology, July 2018, Wolters Kluwer Health

    Pongthorn Narongroeknawin

  26. Effectiveness and Drug Survival of Anti–Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis

    Article • JCR Journal of Clinical Rheumatology, March 2018, Wolters Kluwer Health

    Pongthorn Narongroeknawin

  27. 2016 Thai Rheumatism Association Recommendations for the use of bDMARDs in RA

    Article • International Journal of Rheumatic Diseases, July 2017, Wiley

    Pongthorn Narongroeknawin, Ratanavadee Nanagara

  28. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry

    Article • International Journal of Rheumatic Diseases, November 2016, Wiley

    Pongthorn Narongroeknawin

  29. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association

    Article • International Journal of Rheumatic Diseases, July 2016, Wiley

    Pongthorn Narongroeknawin

  30. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis

    Article • International Journal of Rheumatic Diseases, December 2014, Wiley

    Pongthorn Narongroeknawin

  31. The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort

    Article • Clinical Rheumatology, July 2014, Springer Science + Business Media

    Pongthorn Narongroeknawin

  32. The association between serum vitamin D Level and disease activity in Thai rheumatoid arthritis patients

    Article • International Journal of Rheumatic Diseases, November 2013, Wiley

    Pongthorn Narongroeknawin

  33. Current Daily Glucocorticoid Use and Serum Creatinine Levels Are Associated With Lower 25(OH) Vitamin D Levels in Thai Patients With Systemic Lupus Erythematosus

    Article • JCR Journal of Clinical Rheumatology, April 2013, Wolters Kluwer Health

    Pongthorn Narongroeknawin

  34. Validation of Diagnostic Codes for Subtrochanteric, Diaphyseal, and Atypical Femoral Fractures Using Administrative Claims Data

    Article • Journal of Clinical Densitometry, January 2012, Elsevier

    Pongthorn Narongroeknawin

  35. Bisphosphonate-associated osteonecrosis of the jaw,with healing after teriparatide:a review of the literature and a case report

    Article • Special Care in Dentistry, March 2010, Wiley

    Pongthorn Narongroeknawin

  36. Physician preference motivates the use of anti–tumor necrosis factor therapy independent of clinical disease activity

    Article • Arthritis Care & Research, January 2010, Wiley

    Pongthorn Narongroeknawin

  37. The delivery of evidence-based preventive care for older Americans with arthritis

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    Pongthorn Narongroeknawin

  38. Factors Associated With Osteonecrosis in Thai Lupus Patients

    Article • JCR Journal of Clinical Rheumatology, October 2009, Wolters Kluwer Health

    Pongthorn Narongroeknawin